On the contrary, TRPM7 is downregulated in doxorubicin-resistant colon cancer cell line LoVo-R, therefore its silencing confers further resistance against doxorubicin, suggesting that the reduced expression of TRPM7 is linked to doxorubicin resistance in these cells [196]. Here, TRPM7 is linked to malignant colon neoplasm.